[1] ZHOU H, YUE Y, WANG J, et al. Melatonin therapy for diabetic cardiomyopathy: a mechanism involving Syk-mitochondrial complex I-SERCA pathway[J]. Cell Signal, 2018, 47(1):88-100. [2] 迟庆杰, 王天乐, 祁荣兴. 糖尿病心肌病影像诊断研究进展[J]. 中国临床医学, 2018, 25(5):129-134. [3] 李莎莎, 郁丽霞, 何敖林, 等. 分泌型Klotho作为慢性肾脏病患者血清学标志物的可行性研究进展[J]. 中华肾脏病杂志, 2018, 34(12):956-960. [4] GATEVA A T, ASSYOV Y S, VELIKOVA T, et al. Higher levels of thioredoxin interacting protein (TXNIP) in patients with prediabetes compared to obese normoglycemic subjects[J]. Diabetes Metab Syndr, 2019, 13(1):734-737. [5] 应令雯, 周健. 2017年ADA糖尿病医学诊疗标准解读[J]. 中国医学前沿杂志:电子版, 2017, 9(1):48-55. [6] VAN-STEEN S C, WOODWARD M, CHALMERS J, et al. Haemoglobin glycation index and risk for diabetes-related complications in the action in diabetes and vascular disease: Preterax and diamicron modified release controlled evaluation (ADVANCE) trial[J]. Diabetologia, 2018, 61(4):780-789. [7] 田静, 吕嵘, 郭炜. 线粒体障碍在糖尿病性心肌病中的作用及中医药研究进展[J]. 中国中药杂志, 2018, 43(1):8-14. [8] CUI W, LENG B, WANG G P. Klotho protein inhibits H2O2-induced oxidative injury in endothelial Cells via regulation of PI3K/Akt/Nrf2/HO-1 Pathways[J]. Can J Physiol Pharmacol, 2019, 97(5):370-376. [9] 木尼热·提力瓦力迪, 周萍, 王顺, 等. Klotho蛋白对缺血-再灌注肾损伤大鼠氧化应激的影响[J]. 肾脏病与透析肾移植杂志, 2019, 28(1):36-40. [10]刘洪, 冯小兰, 袁晓玲, 等. 糖尿病患者血清sKlotho、NGAL、MCP-1和TGF-β1的表达及意义[J]. 河北医药, 2019, 41(2):186-189. [11]申甚莉, 刘建辉. Txnip与胰腺β细胞功能障碍和细胞凋亡[J]. 中国现代应用药学, 2018, 35(6):933-936. [12]WANG X, HUANG H, SU C, et al. Cilostazol ameliorates high free fatty acid (FFA)-induced activation of NLRP3 inflammasome in human vascular endothelial cells[J]. Artificial Cells, 2019, 47(1):3704-3710. [13]刘敏洁, 薛现军, 姜蕾, 等. Trx、Txnip和CysC与糖尿病肾病的相关性[J]. 实验与检验医学, 2019, 37(4):710-712. [14]李伟真, 丛莎莎, 高翔. 血清脑钠肽检测在糖尿病心肌病早期诊断中的应用价值[J]. 糖尿病新世界, 2018, 21(6):50-51. [15]ANTONOV I B, KOZLOV K L, PAL’TSEVA E M, et al. Matrix metalloproteinases MMP-1 and MMP-9 and their inhibitor TIMP-1 as markers of dilated cardiomyopathy in patients of different age[J]. Bull Exp Biol Med, 2018, 164(4):550-553. |